Department of Orthopaedics, West China Hospital, Sichuan University, 37# Guoxue Road, Chengdu 610041, People's Republic of China.
Surgeon. 2021 Dec;19(6):e475-e484. doi: 10.1016/j.surge.2020.11.007. Epub 2021 Jan 22.
This study was conducted to assess the survivorship and clinical outcomes of cup-cage reconstruction technique in the revision of THA.
PubMed, OVID, EMBASE, and Cochrane Central Register of Controlled Trials (CENTRAL) up to February 2020 were searched. Studies that reported the clinical and radiological follow-up were identified.
A total of 151 hips (145 patients) in six studies were included. The all-cause revision-free survivorship of cup-cage implant at the end of follow-up was 90.1% (136/151), with a mean follow-up of 64.4 months(range 12-135). The overall complication rate was 23.8% (36 of 151 hips), of which component problem, dislocation, infection and sciatic nerve palsy/injury were relatively common. All included studies reported improved clinical outcomes at the end of follow-up.
Results suggested that revision of THA with a cup-cage has a favourable implant survivorship and clinical outcomes for the treatment of pelvic discontinuity, despite the high complications occurrence rates.
本研究旨在评估杯笼重建技术在 THA 翻修中的生存率和临床结果。
检索了截至 2020 年 2 月的 PubMed、OVID、EMBASE 和 Cochrane 中央对照试验注册库（CENTRAL）。确定了报告临床和影像学随访的研究。
共有 6 项研究的 151 髋（145 例患者）纳入本研究。在随访结束时，杯笼植入物的全因翻修无生存率为 90.1%（136/151），平均随访时间为 64.4 个月（范围 12-135）。总的并发症发生率为 23.8%（36/151 髋），其中组件问题、脱位、感染和坐骨神经麻痹/损伤较为常见。所有纳入的研究均报告了随访结束时临床结果的改善。
结果表明，尽管存在较高的并发症发生率，但使用杯笼进行 THA 翻修对于治疗骨盆不连续性具有良好的植入物生存率和临床结果。
